Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2010
08/12/2010US20100205690 Plants With Increased Yield
08/12/2010US20100205689 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
08/12/2010US20100205688 Increasing tolerance of plants to low light conditions
08/12/2010US20100205684 Chicken embryonic stem cell and method for evaluation thereof
08/12/2010US20100205683 Method for enabling stable expression of transgene
08/12/2010US20100205680 Mammary gland- specific human erytheropoietin expression vector, transgenic animal and method for producing human erythropoietin using same
08/12/2010US20100205678 Oocyte spindle-associated factors improve somatic cell cloning
08/12/2010US20100204453 Antibodies to tumor associated proteins
08/12/2010US20100204311 Normal-tension glaucoma model and method for evaluation of test substances by using same
08/12/2010US20100204307 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
08/12/2010US20100204306 Method of Treating Neurodegenerative Disease
08/12/2010US20100204300 Anti-viral methods and compositions
08/12/2010US20100204280 Cinnamoyl inhibitors of transglutaminase
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204245 Amino-pyridines As Inhibitors Of Beta-secretase
08/12/2010US20100204191 Function-Selective Vitamin D Receptor Agonist
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204133 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing and treating HIV
08/12/2010US20100204128 Novel peptides
08/12/2010US20100204125 Genetic alterations associated with cancer
08/12/2010US20100204105 Glucagon analogues
08/12/2010US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor
08/12/2010US20100204098 Peptides with antifungal activity
08/12/2010US20100204094 Diuretic and natriuretic polypeptides
08/12/2010US20100204091 SIVA Ubiquitination and/or Degradation-Related Activity and Modulators Thereof
08/12/2010US20100203641 Methods and compositions for expressing negative-sense viral rna in canine cells
08/12/2010US20100203640 Antigen Presenting Cells
08/12/2010US20100203639 Compositions and methods for plant genetic modification
08/12/2010US20100203638 Method of Producing High-Density Cultured Tissue and High-Density Cultured Tissue
08/12/2010US20100203637 Fluorescent cell markers
08/12/2010US20100203636 Method for isolating islets of langerhans
08/12/2010US20100203635 Composition and method for enabling proliferation of pluripotent human stem cells
08/12/2010US20100203634 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors
08/12/2010US20100203633 Culture System for Rapid Expansion of Human Embryonic Stem Cells
08/12/2010US20100203632 Methods for controlling stem cell differentiation
08/12/2010US20100203631 Antibodies to alpha-synuclein
08/12/2010US20100203630 In vitro human b lymphopoiesis culture system
08/12/2010US20100203629 Cytoplasmic BKca Channel Intron-Containing mRNAs Contribute to the Intrinsic Excitability of Hippocampal Neurons
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203609 Photocatalytic hydrogen production and polypeptides capable of same
08/12/2010US20100203591 Bioreactor, in particular for NMR spectroscopy
08/12/2010US20100203590 Antibodies that bind interleukin-4 receptor
08/12/2010US20100203585 Calcium-Binding Photoprotein, Gene Encoding the Same, and Use Thereof
08/12/2010US20100203584 Host Cells Used For Production of Recombinant Protein
08/12/2010US20100203575 In Vitro Beating Heart Model
08/12/2010US20100203574 Method and apparatus for cultivating living cells
08/12/2010US20100203570 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
08/12/2010US20100203568 Assay Method For Peptide Specific T-Cells
08/12/2010US20100203543 Biological encoding of large numbers of cells
08/12/2010US20100203510 Ppia marker for diagnosis of liver cancer and antibody, and screening method of compounds useful for inhibiting liver cancer
08/12/2010US20100203503 Genetic polymorphisms associated with myocardial infarction and uses thereof
08/12/2010US20100203478 Customized Dental Prosthesis for Periodontal or Osseointegration and Related Systems and Methods
08/12/2010US20100203218 Novel lysophosphatidic acid acyltransferase genes
08/12/2010US20100203177 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
08/12/2010US20100203144 Immobilized Metallic Nanoparticles as Unique Materials for Therapeutic and Biosensor Applications
08/12/2010US20100203135 Skin Equivalent Culture
08/12/2010US20100203113 Wnt signalling inhibitors, and methods for making and using them
08/12/2010US20100203112 Composition of cationic phospholipid nanoparticles for effective delivery of nucleic acids
08/12/2010US20100203111 G-substrate for the treatment and prevention of parkinson's disease
08/12/2010US20100203101 Bio-membrane for tissue regeneration
08/12/2010US20100203087 Chemorepulsion of cells
08/12/2010US20100203086 Attack of tumor cells with missing, low or aberrant mhc expression by combining non mhc-restricted t-cells/nk-cells and mhc-restricted cells
08/12/2010US20100203081 Viral inhibitory nucleotide sequences and vaccines
08/12/2010US20100203080 Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof
08/12/2010US20100203076 Complexes of rna and cationic peptides for transfection and for immunostimulation
08/12/2010US20100203075 Chlamydia antigens
08/12/2010US20100203073 Hsv-1 epitopes and methods for using same
08/12/2010US20100203072 Circovirus sequences associated with piglet weight loss disease (pwd)
08/12/2010US20100203071 Chimeric antigens
08/12/2010US20100203068 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3
08/12/2010US20100203067 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
08/12/2010US20100203063 Pestivirus species
08/12/2010US20100203057 Novel compounds
08/12/2010US20100203056 Anti-pd-l1 antibodies and their use to enhance t-cell function
08/12/2010US20100203049 Interleukin-10 Antibodies
08/12/2010US20100203046 Fc gamma receptor-binding polypeptide variants and methods related thereto
08/12/2010US20100203044 Dr6 antagonists and uses thereof in treating neurological disorders
08/12/2010US20100203042 Recombinant anti-vla4 antibody molecules
08/12/2010US20100203041 Antibodies to egfl7 and methods for their use
08/12/2010US20100203031 Method for enhancing the cleavage activity of i-crei derived meganucleases
08/12/2010US20100203024 Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy
08/12/2010US20100203023 Enhanced compositions containing cells and extracellular matrix materials
08/12/2010US20100203021 Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom
08/12/2010US20100203013 Treating Hepatitis C Virus Infection
08/12/2010US20100203012 Iap bir domain binding compounds
08/12/2010US20100203011 Mammalian Cytokines; Related Reagents and Methods
08/12/2010US20100202972 Use of gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls)
08/12/2010US20100202968 Method of Providing Disease-Specific Binding Molecules and Targets
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/12/2010US20100202672 Protein Layers And Their Use In Electron Microscopy
08/12/2010CA2756283A1 Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells
08/12/2010CA2751332A1 Culture medium for epithelial stem cells and organoids comprising said stem cells.
08/12/2010CA2751133A1 Tissue engineering of lung
08/12/2010CA2747308A1 Treatment of limb ischemia
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216400A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture
08/11/2010EP2216399A1 Human soluble CD146, preparation and uses thereof
08/11/2010EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/11/2010EP2216342A1 Anti-CD19 antibodies
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1827